(Q34232330)

31 July 2017

Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema (English)

1 reference

cost-effectiveness analysis

31 July 2017

1 reference

Vinay Dewan

1

1 reference

31 July 2017

Dennis Lambert

2

1 reference

31 July 2017

Joshua Edler

3

1 reference

31 July 2017

Steven Kymes

4

1 reference

31 July 2017

Rajendra S Apte

5

1 reference

31 July 2017

13 April 2012

1 reference

31 July 2017

1 reference

31 July 2017

119

1 reference

31 July 2017

8

1 reference

31 July 2017

1679-1684

1 reference

Legislating against use of cost-effectiveness information

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

The economic burden of major adult visual disorders in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

What is the price of life and why doesn't it increase at the rate of inflation?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Diabetic macular edema. A review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

Efficiency, equity, and NICE clinical guidelines

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612959

The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

28 October 2018

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Cost-effectiveness of detecting and treating diabetic retinopathy

1 reference

12 December 2020

Lessons for health technology assessment: it is not only about the evidence

1 reference

12 December 2020

10.1016/J.OPHTHA.2012.01.049

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference